A business in context

IPSC research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-02 · 0001104659-26-113055 · Items 7.01,8.01,9.01

  2. 4 · Ownership change

    Report date 2026-09-11 · 0002001162-26-000018

  3. 4 · Ownership change

    Report date 2026-09-14 · 0001867305-26-000014

  4. 4 · Ownership change

    Report date 2026-09-14 · 0001867173-26-000020

  5. 4 · Ownership change

    Report date 2026-09-09 · 0001452429-26-000005

  6. 4 · Ownership change

    Report date 2026-09-04 · 0002001162-26-000016

  7. 4 · Ownership change

    Report date 2026-09-08 · 0001867305-26-000012

  8. 4 · Ownership change

    Report date 2026-09-08 · 0001867173-26-000018

  9. 8-K · Current report

    Report date 2026-09-09 · 0001104659-26-106312 · Items 5.02,7.01,9.01

  10. 4 · Ownership change

    Report date 2026-08-14 · 0002001162-26-000014

  11. 8-K · Current report

    Report date 2026-08-12 · 0001104659-26-094533 · Items 2.02,7.01,9.01

  12. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-094523

  13. 8-K · Current report

    Report date 2026-06-15 · 0001104659-26-074577 · Items 5.02

  14. 8-K · Current report

    Report date 2026-06-11 · 0001104659-26-073429 · Items 5.03,5.07,9.01

  15. 8-K · Current report

    Report date 2026-06-08 · 0001104659-26-071383 · Items 8.01,9.01

  16. 8-K · Current report

    Report date 2026-05-13 · 0001104659-26-059824 · Items 2.02,9.01

  17. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-059816

  18. DEF 14A · Proxy statement

    Report date 2026-06-11 · 0001104659-26-049489

  19. 8-K · Current report

    Report date 2026-03-26 · 0001104659-26-035256 · Items 8.01,9.01

  20. 8-K · Current report

    Report date 2026-03-12 · 0001104659-26-026761 · Items 2.02,7.01,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-026759

  22. 8-K · Current report

    Report date 2026-01-22 · 0001104659-26-006236 · Items 5.07,8.01

  23. 8-K · Current report

    Report date 2026-01-12 · 0001104659-26-002748 · Items 7.01,9.01

  24. 8-K · Current report

    Report date 2026-01-07 · 0001104659-26-001952 · Items 1.01,3.02,7.01,9.01

  25. 8-K · Current report

    Report date 2025-12-18 · 0001104659-25-124836 · Items 5.02

  26. 8-K · Current report

    Report date 2025-12-12 · 0001104659-25-120654 · Items 7.01,9.01

  27. 8-K · Current report

    Report date 2025-12-09 · 0001104659-25-119494 · Items 5.02,7.01,9.01

  28. DEF 14A · Proxy statement

    Report date 2026-01-22 · 0001104659-25-117704

  29. 8-K · Current report

    Report date 2025-11-13 · 0001104659-25-110862 · Items 2.02,7.01,8.01,9.01

  30. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-110851

  31. 8-K · Current report

    Report date 2025-08-27 · 0001104659-25-085658 · Items 3.01

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-011575

  33. 8-K · Current report

    Report date 2025-08-13 · 0001104659-25-078617 · Items 2.02,5.02,7.01,9.01

  34. 8-K · Current report

    Report date 2025-07-01 · 0001104659-25-066091 · Items 2.05,5.02

  35. 8-K · Current report

    Report date 2025-06-12 · 0001104659-25-059950 · Items 5.07

  36. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-007885

  37. 8-K · Current report

    Report date 2025-05-15 · 0001104659-25-049454 · Items 2.02,7.01,9.01

  38. DEF 14A · Proxy statement

    Report date 2025-06-12 · 0001104659-25-037419

  39. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-003299

  40. 8-K · Current report

    Report date 2025-03-19 · 0001104659-25-025559 · Items 2.02,7.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 5 transaction rows5SGrant / award: 1 transaction rows1AExercise / conversion: 0 transaction rows0MTax / exercise payment: 3 transaction rows3FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

9 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-14
2026-09-15
Russotti GregoryS · Sale
Disposed
Common Stock2587.01.93
2026-09-14
2026-09-15
Carr DouglasS · Sale
Disposed
Common Stock1658.01.93
2026-09-11
2026-09-15
Pfeiffenberger BrentF · Tax / exercise payment
Disposed
Common Stock13850.01.94
2026-09-09
2026-09-10
Truitt JosephA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
148000.00.0
2026-09-08
2026-09-09
Russotti GregoryS · Sale
Disposed
Common Stock534.02.05
2026-09-08
2026-09-09
Carr DouglasS · Sale
Disposed
Common Stock254.02.05
2026-09-04
2026-09-09
Pfeiffenberger BrentF · Tax / exercise payment
Disposed
Common Stock463.02.11
2026-08-14
2026-08-18
Pfeiffenberger BrentF · Tax / exercise payment
Disposed
Common Stock31172.01.92
2026-08-03
2026-08-05
Carr DouglasS · Sale
Disposed
Common Stock275.01.98

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001850119Century Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Century Therapeutics (United States) · alias · wikidata

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$6.59M$7.08M
2023-12-31$2.23M$2.47M
2022-12-31$5.20M$5.98M

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗